Loading bill breakdown…
Loading bill breakdown…
Sponsored by Sen. Markwayne Mullin (R-OK) · 37 active : 17 Republicans, 20 Democrats
Latest action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mikaela Naylon Give Kids a Chance Act of 2025
This bill authorizes certain targeted clinical trials involving combinations of drugs to treat pediatric cancer, and renews the Food and Drug Administration’s (FDA’s) authority to award priority review vouchers (PRVs) to sponsors of new products for rare pediatric diseases.
Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs used in combination with active ingredients that have already been approved and that (1) have been determined to be part of the standard of care for treating a pediatric cancer, or (2) have been approved to treat an adult cancer and are directed at molecular targets for pediatric cancer.
The FDA must issue guidance on the implementation of these provisions and report to Congress on its efforts to ensure implementation. The Government Accountability Office (GAO) must report on the effectiveness of the bill's changes with respect to the development of pediatric cancer drugs.
The bill also renews the FDA’s authority to issue PRVs to sponsors of new products intended to treat rare pediatric diseases through September 30, 2030. This is known as the Rare Pediatric Disease PRV program. The program expired in December 2024.
GAO must report on the effectiveness of the Rare Pediatric Disease PRV program, including to what extent PRVs were successful in promoting drug development and expediting patient access to drugs for the treatment or prevention of rare pediatric diseases.
No legislative subjects recorded yet. Similar-vote matching falls back to the policy area.
Members fall into . All 100 senators have enough data to score.
: only movement toward the other party counts, so members who sit further from the center than their party no longer score as swing votes.
Bars show each input from 0 to 100: ideology gap, scorecard gap, , and the . is the seat’s partisan lean, and shows how much of the input data a score has.
Loading similar votes


Ideology is each member’s score. The cluster low on the chart includes the bill’s 37 sponsor and cosponsors in the Senate: they have already committed, so they score as entrenched.
Not applicable in the Senate. There is not enough similar voting history (weight 4.5 of 5.0 needed), so this input is left out of the score rather than counted as missing.